Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides.
暂无分享,去创建一个
[1] W S Hancock,et al. Analysis of Oligonucleotides by HPLC-Electrospray Ionization Mass Spectrometry. , 1997, Analytical chemistry.
[2] R. Diasio,et al. Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV‐infected subjects , 1995, Clinical pharmacology and therapeutics.
[3] L. Cummins,et al. On-line HPLC electrospray mass spectrometry of phosphorothioate oligonucleotide metabolites. , 1997, Analytical chemistry.
[4] R. Griffey,et al. Characterization of Oligonucleotide MetabolismIn Vivovia Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer , 1997 .
[5] S. Stavchansky,et al. Determination of single-stranded oligodeoxynucleotides by capillary gel electrophoresis with laser induced fluorescence and on column derivatization. , 1996, Journal of chromatography. A.
[6] P. Nicklin,et al. Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration. , 1997, Biochemical pharmacology.
[7] Peter Natesan Pushparaj,et al. SHORT INTEFERING RNA (siRNA) AS A NOVEL THERAPEUTIC , 2006, Clinical and Experimental Pharmacology and Physiology.
[8] W. Guo,et al. Quantification of raf antisense oligonucleotide (rafAON) in biological matrices by LC-MS/MS to support pharmacokinetics of a liposome-entrapped rafAON formulation. , 2005, Biomedical chromatography : BMC.
[9] C. Bloomfield,et al. Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Yuan-Qing Xia,et al. LC-MS Development strategies for quantitative bioanalysis. , 2006, Current drug metabolism.
[11] J. Gebler,et al. Analysis of native and chemically modified oligonucleotides by tandem ion-pair reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[12] J. Rozenski,et al. Interpretation of oligonucleotide mass spectra for determination of sequence using electrospray ionization and tandem mass spectrometry. , 1996, Analytical chemistry.
[13] J. Banoub,et al. Recent developments in mass spectrometry for the characterization of nucleosides, nucleotides, oligonucleotides, and nucleic acids. , 2005, Chemical reviews.
[14] S. Crooke,et al. Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration. , 2001, Biochemical pharmacology.
[15] R. S. Coleman,et al. Analysis of post-synthetically modified oligodeoxynucleotides by electrospray ionization mass spectrometry. , 1994 .
[16] K. Bleicher,et al. Various factors influencing the signal intensity of oligonucleotides in electrospray mass spectrometry. , 1994, Biological mass spectrometry.
[17] C. Huber,et al. Sheath liquid effects in capillary high-performance liquid chromatography-electrospray mass spectrometry of oligonucleotides. , 2000, Journal of chromatography. A.
[18] S. Ito,et al. Enhanced mass detection of oligonucleotides using reverse-phase high-performance liquid chromatography/electrospray ionization ion-trap mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.
[19] A. Krieg,et al. Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration. , 2005, Biochemical pharmacology.
[20] Demin Zhou,et al. RNA interference and potential applications. , 2006, Current topics in medicinal chemistry.
[21] Kim Hartsough,et al. Liquid chromatography/electrospray mass spectrometric analysis of metabolites from an inhibitory RNA duplex. , 2005, Rapid communications in mass spectrometry : RCM.
[22] C. Huber,et al. Analysis of nucleic acids by capillary ion-pair reversed-phase HPLC coupled to negative-ion electrospray ionization mass spectrometry. , 1999, Analytical chemistry.
[23] C. V. Van Peteghem,et al. Analysis of nucleic acid constituents by on‐line capillary electrophoresis‐mass spectrometry , 2005, Electrophoresis.
[24] L. Cummins,et al. PHOSPHOROTHIOATE OLIGONUCLEOTIDE METABOLISM: CHARACTERIZATION OF THE “N+”-MER BY CE AND HPLC-ES/MS , 1997 .
[25] J. Gebler,et al. Characterization of therapeutic oligonucleotides using liquid chromatography with on-line mass spectrometry detection. , 2003, Oligonucleotides.
[26] M. Gilar. Analysis and purification of synthetic oligonucleotides by reversed-phase high-performance liquid chromatography with photodiode array and mass spectrometry detection. , 2001, Analytical biochemistry.
[27] E. Nordhoff,et al. Mass spectrometry of nucleic acids. , 1996, Mass spectrometry reviews.
[28] Jennifer A. Lockridge,et al. Liquid chromatography electrospray ionization mass spectrometry analysis of the ocular metabolites from a short interfering RNA duplex. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[29] A. Bruins. Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied Topics , 1998 .
[30] Chow H Lee,et al. Destroying RNA as a therapeutic approach. , 2006, Current medicinal chemistry.
[31] A. Levin,et al. Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys. , 2004, Journal of pharmaceutical sciences.
[32] I. Ahmad,et al. Mass spectrometry and enzyme-linked immunosorbent assay methods for the quantitation of liposomal antisense oligonucleotide (LE-rafAON) in human plasma. , 2004, Methods in enzymology.
[33] R. Yu,et al. Development of an Ion-Pair Reverse-Phase Liquid Chromatographic/Tandem Mass Spectrometry Method for the Determination of an 18-Mer Phosphorothioate Oligonucleotide in Mouse Liver Tissue , 2005, European journal of mass spectrometry.
[34] A. Levin,et al. Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma. , 2002, Analytical biochemistry.
[35] Herbert Oberacher,et al. Effect of instrument tuning on the detectabilityof biopolymers in electrospray ionization mass spectrometry. , 2003, Journal of mass spectrometry : JMS.
[36] Claes Wahlestedt,et al. RNA Interference with chemically modified siRNA. , 2006, Current topics in medicinal chemistry.
[37] E. Ezan,et al. A competitive enzyme hybridization assay for plasma determination of phosphodiester and phosphorothioate antisense oligonucleotides. , 1997, Nucleic acids research.
[38] M. Colgrave,et al. Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins. , 2001, Mass spectrometry reviews.
[39] P. Iversen,et al. Bioavailability and efficacy of antisense morpholino oligomers targeted to c-myc and cytochrome P-450 3A2 following oral administration in rats. , 2002, Journal of pharmaceutical sciences.
[40] G. Marcucci,et al. Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[41] G. Siuzdak,et al. Liquid chromatography mass spectrometry of antisense oligonucleotides , 1995 .
[42] G. Hardee,et al. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[43] C. Huber,et al. Analysis of nucleic acids by on-line liquid chromatography-mass spectrometry. , 2001, Mass spectrometry reviews.
[44] T. Krugh,et al. Large-scale purification of synthetic oligonucleotides and carcinogen-modified oligodeoxynucleotides on a reverse-phase polystyrene (PRP-1) column. , 1990, Analytical biochemistry.
[45] M. Graham,et al. Metabolism of antisense oligonucleotides in rat liver homogenates. , 2000, The Journal of pharmacology and experimental therapeutics.
[46] R. Griffey,et al. Utility of organic bases for improved electrospray mass spectrometry of oligonucleotides. , 1995, Rapid communications in mass spectrometry : RCM.
[47] A. Levin,et al. Application of novel quantitative bioanalytical methods for pharmacokinetic and pharmacokinetic/pharmacodynamic assessments of antisense oligonucleotides. , 2004, Current opinion in drug discovery & development.
[48] M. Graham,et al. Quantitation of phosphorothioate oligonucleotides in human plasma. , 1996, Analytical biochemistry.